Randolph Co Inc adds Anthem Inc (ANTM) to its portfolio

Anthem Inc (ANTM) : Randolph Co Inc added new position in Anthem Inc during the most recent quarter end. The investment management firm now holds 62,315 shares of Anthem Inc which is valued at $7,596,199 , the company said in a statement filed on Oct 7, 2016 with the SEC.Anthem Inc makes up approximately 1.94% of Randolph Co Inc’s portfolio.

Other Hedge Funds, Including , New England Research Management sold out all of its stake in ANTM during the most recent quarter. The investment firm sold 5,450 shares of ANTM which is valued $665,282.Bnp Paribas Arbitrage Sa reduced its stake in ANTM by selling 8,624 shares or 19.03% in the most recent quarter. The Hedge Fund company now holds 36,699 shares of ANTM which is valued at $4,479,847. Anthem Inc makes up approx 0.02% of Bnp Paribas Arbitrage Sa’s portfolio.Eqis Capital Management reduced its stake in ANTM by selling 1,472 shares or 21.35% in the most recent quarter. The Hedge Fund company now holds 5,424 shares of ANTM which is valued at $662,108. Anthem Inc makes up approx 0.04% of Eqis Capital Management’s portfolio.

Anthem Inc closed down -0.45 points or -0.37% at $121.9 with 16,99,220 shares getting traded on Friday. Post opening the session at $122.28, the shares hit an intraday low of $120.78 and an intraday high of $122.74 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Anthem Inc reported $3.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.23. The company had revenue of $21274.50 million for the quarter, compared to analysts expectations of $20512.60 million. The company’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.10 EPS.

Many Wall Street Analysts have commented on Anthem Inc. Shares were Downgraded by Jefferies on Sep 13, 2016 to ” Hold” and Lowered the Price Target to $ 138 from a previous price target of $156 .Shares were Reiterated by Barclays on Jul 28, 2016 to “Equal Weight” and Lowered the Price Target to $ 151 from a previous price target of $158 .

Anthem Inc. is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer individual Medicaid and Medicare markets. Its managed care plans include preferred provider organizations (PPOs) health maintenance organizations (HMOs) point-of-service (POS) plans traditional indemnity plans and other hybrid plans including consumer-driven health plans (CDHPs) and hospital only and limited benefit products. In addition the Company also provides an array of managed care services to self-funded customers including claims processing underwriting stop loss insurance actuarial services provider network access medical cost management disease management wellness programs and other administrative services. The Company provides an array of specialty and other insurance products and services such as dental vision life and disability insurance benefits radiology benefit management and analytics-driven personal health care.

Leave a Reply

Anthem Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Anthem Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.